Shares of Pine Labs Limited fell as much as 11% on May 13, making it one of the top losers on the NSE, after approximately 92.4 crore shares — representing nearly 80% of the company’s outstanding equity — became eligible for trading following the expiry of the six-month IPO lock-in period.
The stock was trading at ₹168.99 on the NSE at 11:27 am, down ₹19.02 or 10.12% from its previous close of ₹188.01. The intraday low touched ₹167.10 against an opening near ₹184.94, with a steady and unrelenting sell-off pattern visible through the morning session. Market capitalisation stands at approximately ₹19,394 crore. The stock carries no P/E ratio given its profitability profile and pays no dividend. Average daily volume is 25.5 lakh shares.
What triggered today’s Pine Labs sell-off?
According to Nuvama Alternative and Quantitative Research, the shares unlocked after the lock-in expiry are valued at approximately ₹17,346 crore based on Tuesday’s closing price — making this one of the larger single-day lock-in expiries seen in India’s recent IPO market. The sheer scale of newly tradeable equity — 80% of outstanding shares — creates significant overhang risk as the market prices in the possibility that early investors and pre-IPO shareholders may choose to exit at least part of their positions.
The lock-in expiry does not mean all eligible shares will be sold immediately — shareholders retain the choice of whether and when to trade their newly unlocked shares. However, the market typically prices in a discount during the lock-in expiry period to account for potential supply, creating the pattern of sharp selling visible in Pine Labs’ May 13 price action.
Pine Labs IPO and listing context
Pine Labs, the digital payments platform focused on point-of-sale technology and merchant payment solutions, made its stock market debut in November 2025, listing at approximately ₹242 per share on the NSE — a premium of nearly 9.5% over its IPO price. The ₹3,900 crore IPO was subscribed approximately 2.5 times, a moderate reception compared to some high-profile IPOs of the period.
At the current price of ₹168.99, Pine Labs is trading approximately 30% below its listing price of ₹242 and well below its 52-week high of ₹284 — a significant decline from peak levels that reflects both the broader pressure on fintech and digital payments valuations and the specific overhang from today’s lock-in expiry. The stock is, however, above its 52-week low of ₹151.12, providing some support context.
What are Pine Labs’ recent financial metrics?
Pine Labs is scheduled to announce its Q4 FY26 earnings on May 25 — a catalyst that could provide directional clarity on the stock’s near-term trajectory. In Q3 FY26, the company reported a net profit of ₹42 crore, compared to a net loss of ₹58 crore in Q3 FY25 — a meaningful turnaround at the bottom line. Operating revenue for Q3 FY26 rose 23% year-on-year to ₹744 crore from ₹601 crore, while expenses grew at a slower 13% pace to ₹704 crore — indicating improving operating leverage. The Q4 FY26 results on May 25 will be the first post-lock-in earnings event and are likely to be a significant stock price catalyst in either direction.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to consult a registered financial advisor before making any investment decisions. Business Upturn does not hold any position in the securities mentioned.